Predictors of surgery types after neoadjuvant therapy for advanced stage breast cancer: Analysis from Florida population-based cancer registry (1996-2009)

Jamila Al-Azhri, Tulay Sengul, Feng Miao, Constantine Saclarides, Margaret M Byrne, Eli Avisar

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

PURPOSE: Despite the established guidelines for breast cancer treatment, there is still variability in surgical treatment after neoadjuvant therapy (NT) for women with large breast tumors. Our objective was to identify predictors of the type of surgical treatment: mastectomy versus breast-conserving surgery (BCS) in women with T3/T4 breast cancer who received NT. METHODS: Population-based Florida Cancer Data System Registry, Florida’s Agency for Health Care Administration, and US census from 1996 to 2009 were linked for women diagnosed with T3/T4 breast cancer and received NT followed by either BCS or mastectomy. Analysis of multiple variables, such as sociodemographic characteristics (race, ethnicity, socioeconomic status, age, marital status, and urban/rural residency), tumor’s characteristics (estrogen/progesterone receptor status, histology, grade, SEER stage, and regional nodes positivity), treatment facilities (hospital volume and teaching status), patients’ comorbidities, and type of NT, was performed. RESULTS: Of 1,056 patients treated with NT for T3/T4 breast cancer, 107 (10%) had BCS and 949 (90%) had mastectomy. After adjusting with extensive covariables, Hispanic patients (adjusted odds ratio (aOR) = [3.50], 95% confidence interval (CI): 1.38-8.84, P = 0.008) were more likely to have mastectomy than BCS. Compared to localized SEER stage, regional stage with direct extension (aOR = [3.24], 95% CI: 1.60-6.54, P = 0.001), regional stage with direct extension and nodes (aOR = [4.35], 95% CI: 1.72-11.03, P = 0.002), and distant stage (aOR = [4.44], 95% CI: 1.81-10.88, P = 0.001) were significantly more likely to have mastectomy than BCS. Compared to patients who received both chemotherapy and hormonal therapy, patients who received hormonal NT only (aOR = [0.29], 95% CI: 0.12-0.68, P = 0.004) were less likely to receive mastectomy. CONCLUSION: Our study suggests that Hispanic ethnicity, advanced SEER stage, and type of NT are significant predictors of receiving mastectomy after NT.

Original languageEnglish (US)
Pages (from-to)99-108
Number of pages10
JournalBreast Cancer: Basic and Clinical Research
Volume2015
Issue number9
DOIs
StatePublished - Dec 13 2015

Keywords

  • Breast cancer
  • Lumpectomy
  • Mastectomy
  • Neoadjuvant
  • Predictors
  • SEER

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Predictors of surgery types after neoadjuvant therapy for advanced stage breast cancer: Analysis from Florida population-based cancer registry (1996-2009)'. Together they form a unique fingerprint.

  • Cite this